Insights
Starting January 1, 2027, the 340B landscape may shift following the Health Resources and Services Administration’s (HRSA) implementation of the revised 340B Rebate Model Pilot Program Pilot Program
Pages
Pages
Pages
Insights
This study assesses the pharmacist impact within an ATTR-CM specialty program by characterizing documented interventions and associated outcomes.
Pages
Pages
Insights
This study assess the impact of a health system specialty pharmacy program on operational and clinical outcomes for patients on hGH.
News
The onsite specialty pharmacy will streamline access to medications, enhance care coordination, and improve patient outcomes.
Insights
With the right partner, you can accelerate your specialty pharmacy program’s potential while retaining full ownership and staying true to your mission. Learn how.
Pages
Insights
The 5th Annual Shields Specialty Pharmacy Outcomes Report is here. Featuring results from more than 2 million patients across 50+ integrated disease states and nearly 80 health system partners.
